184 related articles for article (PubMed ID: 35028860)
1. Midkine promotes breast cancer cell proliferation and migration by upregulating NR3C1 expression and activating the NF-κB pathway.
Zhang L; Song L; Xu Y; Xu Y; Zheng M; Zhang P; Wang Q
Mol Biol Rep; 2022 Apr; 49(4):2953-2961. PubMed ID: 35028860
[TBL] [Abstract][Full Text] [Related]
2. Silence of TPPP3 suppresses cell proliferation, invasion and migration via inactivating NF-κB/COX2 signal pathway in breast cancer cell.
Ren Q; Hou Y; Li X; Fan X
Cell Biochem Funct; 2020 Aug; 38(6):773-781. PubMed ID: 32515139
[TBL] [Abstract][Full Text] [Related]
3. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway.
Yi T; Zhou X; Sang K; Huang X; Zhou J; Ge L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3765-3773. PubMed ID: 31556319
[TBL] [Abstract][Full Text] [Related]
4. Sufentanil inhibits the metastasis and immune response of breast cancer via mediating the NF-κB pathway.
Li M; Gu K; Kong Q; Wang G; Gu J
Immunopharmacol Immunotoxicol; 2023 Dec; 45(6):663-671. PubMed ID: 37358084
[TBL] [Abstract][Full Text] [Related]
5. Tumor-promoting properties of enolase-phosphatase 1 in breast cancer via activating the NF-κB signaling pathway.
Bu Y; Hao J; He J; Li X; Liu Y; Ma L
Mol Biol Rep; 2023 Feb; 50(2):993-1004. PubMed ID: 36378417
[TBL] [Abstract][Full Text] [Related]
6. PLCA8 suppresses breast cancer apoptosis by activating the PI3k/AKT/NF-κB pathway.
Mao M; Chen Y; Jia Y; Yang J; Wei Q; Li Z; Chen L; Chen C; Wang L
J Cell Mol Med; 2019 Oct; 23(10):6930-6941. PubMed ID: 31448883
[TBL] [Abstract][Full Text] [Related]
7. CircRNF10-DHX15 interaction suppressed breast cancer progression by antagonizing DHX15-NF-κB p65 positive feedback loop.
Zheng W; Wang X; Yu Y; Ji C; Fang L
Cell Mol Biol Lett; 2023 Apr; 28(1):34. PubMed ID: 37101128
[TBL] [Abstract][Full Text] [Related]
8. Silence of Stomatin-Like Protein 2 Represses Migration and Invasion Ability of Human Liver Cancer Cells via Inhibiting the Nuclear Factor Kappa B (NF-κB) Pathway.
Zhu W; Li W; Geng Q; Wang X; Sun W; Jiang H; Pu X
Med Sci Monit; 2018 Oct; 24():7625-7632. PubMed ID: 30359340
[TBL] [Abstract][Full Text] [Related]
9. Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF-κB activation mediated by IL-4/miR-324-5p/CUEDC2 axis.
Song L; Liu D; Zhao Y; He J; Kang H; Dai Z; Wang X; Zhang S; Zan Y
Biochem Biophys Res Commun; 2015 Aug; 464(3):705-10. PubMed ID: 26166821
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA (LncRNA) CASC9/microRNA(miR)-590-3p/sine oculis homeobox 1 (SIX1)/NF-κB axis promotes proliferation and migration in breast cancer.
Chang J; Zhang Y; Ye X; Guo H; Lu K; Liu Q; Guo Y
Bioengineered; 2021 Dec; 12(1):8709-8723. PubMed ID: 34711117
[TBL] [Abstract][Full Text] [Related]
11. Silencing KPNA2 inhibits IL-6-induced breast cancer exacerbation by blocking NF-κB signaling and c-Myc nuclear translocation in vitro.
Duan M; Hu F; Li D; Wu S; Peng N
Life Sci; 2020 Jul; 253():117736. PubMed ID: 32360571
[TBL] [Abstract][Full Text] [Related]
12. Crocin attenuates NF-κB-mediated inflammation and proliferation in breast cancer cells by down-regulating PRKCQ.
Xu Q; Yu J; Jia G; Li Z; Xiong H
Cytokine; 2022 Jun; 154():155888. PubMed ID: 35447530
[TBL] [Abstract][Full Text] [Related]
13. Oroxylin A Suppresses the Cell Proliferation, Migration, and EMT via NF-
Sun X; Chang X; Wang Y; Xu B; Cao X
Biomed Res Int; 2019; 2019():9241769. PubMed ID: 31341911
[TBL] [Abstract][Full Text] [Related]
14. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW
Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040
[TBL] [Abstract][Full Text] [Related]
15. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.
Tsubaki M; Komai M; Fujimoto S; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
J Exp Clin Cancer Res; 2013 Sep; 32(1):62. PubMed ID: 24011086
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rh1 Prevents Migration and Invasion through Mitochondrial ROS-Mediated Inhibition of STAT3/NF-κB Signaling in MDA-MB-231 Cells.
Jin Y; Huynh DTN; Myung CS; Heo KS
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638797
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways.
Ahmad A; Wang Z; Kong D; Ali R; Ali S; Banerjee S; Sarkar FH
Breast Cancer Res Treat; 2011 Feb; 126(1):15-25. PubMed ID: 20379844
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of RPA2 promotes NF-κB activation in breast cancer by relieving the antagonistic function of menin on NF-κB-regulated transcription.
Chen CC; Juan CW; Chen KY; Chang YC; Lee JC; Chang MC
Carcinogenesis; 2017 Feb; 38(2):196-206. PubMed ID: 28007956
[TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNA NKILA Reduces Oral Squamous Cell Carcinoma Development Through the NF-KappaB Signaling Pathway.
Hu D; Zhong T; Dai Q
Technol Cancer Res Treat; 2020; 19():1533033820960747. PubMed ID: 33143574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
